Ozempic .5 mg/.5mL
semaglutide · INJECTION, SOLUTION · Novo Nordisk Pharmaceutical Industries, LP
No Recall HistoryCurrently in Shortage
Plain English
Ozempic is a injection, solution containing semaglutide at .5 mg/.5mL, taken subcutaneous. Manufactured by Novo Nordisk Pharmaceutical Industries, LP.
Key Facts
- Brand Name
- Ozempic
- Generic Name
- semaglutide
- NDC Code (Product)
0169-1305- Manufacturer
- Novo Nordisk Pharmaceutical Industries, LP
- Strength
- .5 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA209637
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 10/07/2022
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
nausea9,384 reports
off label use6,339 reports
vomiting6,203 reports
diarrhoea5,743 reports
decreased appetite4,169 reports
constipation4,053 reports
weight decreased3,832 reports
fatigue2,865 reports
product use in unapproved indication2,841 reports
headache2,807 reports
Frequently Asked Questions
What is Ozempic used for?
Ozempic contains semaglutide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Ozempic a controlled substance?
Ozempic is not classified as a controlled substance by the DEA.
What is the generic name for Ozempic?
The generic name for Ozempic is semaglutide. There are 8 other brand versions of semaglutide.
What is the NDC code for Ozempic .5 mg/.5mL?
The NDC (National Drug Code) for Ozempic .5 mg/.5mL is 0169-1305, listed by Novo Nordisk Pharmaceutical Industries, LP.